BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years

Published:2012-02-14 Issue:6 Volume:106 Page:1234-1238
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Robertson L, ,Hanson H,Seal S,Warren-Perry M,Hughes D,Howell I,Turnbull C,Houlston R,Shanley S,Butler S,Evans D G,Ross G,Eccles D,Tutt A,Rahman N

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201231.pdf

Reference26 articles.

1. American Society of Clinical Oncology ( 2003 ) American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility . J Clin Oncol 21 : 2397 – 2406

2. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF ( 2003 ) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies . Am J Hum Genet 72 : 1117 – 1130

3. Antoniou AC, Hardy R, Walker L, Evans DG, Shenton A, Eeles R, Shanley S, Pichert G, Izatt L, Rose S, Douglas F, Eccles D, Morrison PJ, Scott J, Zimmern RL, Easton DF, Pharoah RPD ( 2008 ) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics . J Med Genet 45 : 425 – 431

4. Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, Hortobagyi GN, Arun BK ( 2008 ) Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer . J Clin Oncol 26 : 4282 – 4288

5. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V ( 2007 ) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry . Cancer 109 : 1721 – 1728

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Manchester Scoring System for predicting BRCA1/2 mutations underperforms in Arabic Omani breast cancer patients;Journal of Genetic Counseling;2024-06-18

2. The Effects of National Insurance Coverage Expansion and Genetic Counseling’s Role on BRCA1/2 Mutation Tests in Breast Cancer Patients;Cancers;2024-05-14

3. BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients;Egyptian Journal of Medical Human Genetics;2024-02-08

4. Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward;Plants;2023-06-16

5. A phase Ib study of TQB2450 plus anlotinib in patients with advanced triple-negative breast cancer;iScience;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3